The company plans to prioritize growth in Germany and Poland, leveraging its good manufacturing practice-certified facilities to chase higher margins. Management expects this geographic shift to improve profitability, yet the transition—compounded by April’s reductions in government-reimbursed pricing in Canada—will drive net revenue lower in fiscal 2027. Investors have responded sharply to the outlook, extending the stock's year-to-date losses to 30%.
Aurora Cannabis Slides as Strategic Pivot Triggers Revenue Forecast Cut
Shares of Aurora Cannabis tumbled 9.1% to $2.99 on Thursday, briefly touching a three-year low of $2.73, after the company signaled a forthcoming revenue contraction. The decline follows a strategic decision to abandon Canadian consumer operations in favor of expanding production capacity within the European Union.
Comments (0)
No comments yet. Be the first!